The market for cardiac output monitoring includes pulmonary artery catheters (PAC), minimally invasive, and non-invasive monitoring devices as well as the sensors associated with each of these modalities. In recent years, less invasive technologies have displaced the PAC, as physicians move towards reliable techniques that reduce the impact on patients. However, while less invasive solutions continue to gain traction, it has been suggested that they are not as accurate when compared with traditional PAC thermodilution methods. As such, PAC procedures are still considered the gold standard for calculating cardiac output as well as performing other essential measurements related to drug administration, particularly in high risk surgical theaters.
The total cardiac output market will continue to see strong growth over the forecast period due to increased awareness of the efficacy of CO monitoring. This measurement has become an integral part of critical care practice and may help in facilitating improved patient outcomes. Operating rooms (ORs) have traditionally been the primary users of cardiac output monitoring and pulmonary artery catheters (PACs). Newer therapies are geared toward quickly identifying patient conditions on the front line, namely within intensive care units (ICUs) and emergency rooms (ERs), where CO may be utilized as an early warning indicator for circulatory disturbances.
Cardiac output (CO) refers to the volume of blood being pumped by the heart. Monitoring of patient cardiac output is rapidly becoming a standard of care and a vital part of early diagnosis and treatment. It is also important in the management of heart attacks and for monitoring of sepsis patients. The inclusion of cardiac output monitoring in treatments provides valuable information on the volume tissue perfusion and oxygen delivery. Low-cardiac output indicates that there is insufficient circulation and potential starvation of vital internal organs. In instances of low cardiac output, circulation will be diverted from the gut in order to supply the heart, brain and skeletal muscles with oxygen. Insufficient volumes of oxygen and glucose to cells can cause irreversible damage and result in deterioration of the patients’ condition, possibly leading to death.
'
TABLE OF CONTENTS I
LIST OF FIGURES III
LIST OF CHARTS V
EXECUTIVE SUMMARY 1
U.S. PATIENT MONITORING DEVICE AND EQUIPMENT MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKETS INCLUDED 12
MARKET DEVELOPMENTS 17
KEY REPORT UPDATES 19
VERSION HISTORY 20
RESEARCH METHODOLOGY 21
1.1 RESEARCH SCOPE 21
1.2 IDATA’S 9-STEP METHODOLOGY 21
1.2.1 Step 1: Project Initiation & Team Selection 21
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 23
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design 24
1.2.4 Step 4: Performing Primary Research 25
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 27
1.2.6 Step 6: Market Forecast and Analysis 28
1.2.7 Step 7: Identify Strategic Opportunities 30
1.2.8 Step 8: Final Review and Market Release 31
1.2.9 Step 9: Customer Feedback and Market Monitoring 32
CARDIAC OUTPUT MONITORING MARKET 33
2.1 INTRODUCTION 33
2.1.1 The Fick Principle 33
2.1.2 Dilution Methods 34
2.1.3 Doppler Ultrasound Methods 34
2.1.4 Pulse Pressure Methods 35
2.1.5 Other Methods 35
2.2 MARKET OVERVIEW 36
2.3 MARKET ANALYSIS AND FORECAST 40
2.3.1 Total Pulmonary Artery Catheter Market 40
2.3.1.1 Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market 43
2.3.1.2 Specialty Pulmonary Artery Catheter Market 45
2.3.2 Total Minimally Invasive Cardiac Output Monitoring Market 47
2.3.2.1 Minimally Invasive Cardiac Output Monitor Market 50
2.3.2.2 Minimally Invasive Cardiac Output Sensor Market 52
2.3.3 Total Non-Invasive Cardiac Output Monitoring Market 54
2.3.3.1 Non-Invasive Cardiac Output Monitor Market 57
2.3.3.2 Non-Invasive Cardiac Output Sensor Market 59
2.4 DRIVERS AND LIMITERS 61
2.4.1 Market Drivers 61
2.4.2 Market Limiters 61
2.5 COMPETITIVE MARKET SHARE ANALYSIS 64
ABBREVIATIONS 69
Chart 1 1: Patient Monitoring Device and Equipment Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Patient Monitoring Device and Equipment Market Overview, U.S., 2016 & 2023 3
Chart 2 1: Cardiac Output Monitoring Market by Segment, U.S., 2013 – 2023 38
Chart 2 2: Cardiac Output Monitoring Market Breakdown, U.S., 2016 39
Chart 2 3: Cardiac Output Monitoring Market Breakdown, U.S., 2023 39
Chart 2 4: Pulmonary Artery Catheter Market, U.S., 2013 – 2023 42
Chart 2 5: Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market, U.S., 2013 – 2023 44
Chart 2 6: Specialty Pulmonary Artery Catheter Market, U.S., 2013 – 2023 46
Chart 2 7: Minimally Invasive Cardiac Output Monitoring Market, U.S., 2013 – 2023 49
Chart 2 8: Minimally Invasive Cardiac Output Monitor Market, U.S., 2013 – 2023 51
Chart 2 9: Minimally Invasive Cardiac Output Sensor Market, U.S., 2013 – 2023 53
Chart 2 10: Non-Invasive Cardiac Output Monitoring Market, U.S., 2013 – 2023 56
Chart 2 11: Non-Invasive Cardiac Output Monitor Market, U.S., 2013 – 2023 58
Chart 2 12: Non-Invasive Cardiac Output Sensor Market, U.S., 2013 – 2023 60
Chart 2 13: Leading Competitors, Cardiac Output Monitoring Market, U.S., 2016 68
Figure 1 1: Patient Monitoring Device and Equipment Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Patient Monitoring Device and Equipment Market Share Ranking by Segment, U.S., 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, U.S., 2016 (1 of 2) 6
Figure 1 4: Companies Researched in this Report, U.S., 2016 (2 of 2) 7
Figure 1 5: Factors Impacting the Patient Monitoring Device and Equipment Market by Segment, U.S. (1 of 4) 8
Figure 1 6: Factors Impacting the Patient Monitoring Device and Equipment Market by Segment, U.S. (2 of 4) 9
Figure 1 7: Factors Impacting the Patient Monitoring Device and Equipment Market by Segment, U.S. (3 of 4) 10
Figure 1 8: Factors Impacting the Patient Monitoring Device and Equipment Market by Segment, U.S. (4 of 4) 11
Figure 1 9: Patient Monitoring Device and Equipment Markets Covered, U.S., 2016 (1 of 5) 12
Figure 1 10: Patient Monitoring Device and Equipment Markets Covered, U.S., 2016 (2 of 5) 13
Figure 1 11: Patient Monitoring Device and Equipment Markets Covered, U.S., 2016 (3 of 5) 14
Figure 1 12: Patient Monitoring Device and Equipment Markets Covered, U.S., 2016 (4 of 5) 15
Figure 1 13: Patient Monitoring Device and Equipment Markets Covered, U.S., 2016 (5 of 5) 16
Figure 1 14: Recent Events in the Patient Monitoring Device and Equipment Market, U.S., 2012 – 2016 (1 of 2) 17
Figure 1 15: Recent Events in the Patient Monitoring Device and Equipment Market, U.S., 2012 – 2016 (2 of 2) 18
Figure 1 16: Key Report Updates (1 of 2) 19
Figure 1 17: Key Report Updates (2 of 2) 20
Figure 1 18: Version History 20
Figure 2 1: Cardiac Output Monitoring Market by Segment, U.S., 2013 – 2023 (US$M) 37
Figure 2 2: Total Pulmonary Artery Catheter Market, U.S., 2013 – 2023 41
Figure 2 3: Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market, U.S., 2013 – 2023 43
Figure 2 4: Specialty Pulmonary Artery Catheter Market, U.S., 2013 – 2023 45
Figure 2 5: Total Minimally Invasive Cardiac Output Monitoring Market, U.S., 2013 – 2023 48
Figure 2 6: Minimally Invasive Cardiac Output Monitor, U.S., 2013 – 2023 50
Figure 2 7: Minimally Invasive Cardiac Output Sensor Market, U.S., 2013 – 2023 52
Figure 2 8: Total Non-Invasive Cardiac Output Monitoring Market, U.S., 2013 – 2023 55
Figure 2 9: Non-Invasive Cardiac Output Monitor Market, U.S., 2013 – 2023 57
Figure 2 10: Non-Invasive Cardiac Output Sensor Market, U.S., 2013 – 2023 59
Figure 2 11: Drivers and Limiters, Cardiac Output Monitoring Market, U.S., 2016 63
Figure 2 12: Leading Competitors, Cardiac Output Monitoring Market, U.S., 2016 67
Medtronic
Philips Healthcare
Masimo
GE Healthcare
Edwards Lifesciences
Mindray Medical
Natus Medical
Honeywell Life Sciences
Welch Allyn
Omron Healthcare
Nihon Kohden
Spacelabs Healthcare
St. Jude Medical
Nonin Medical
Boston Scientific
Others include: • A&D Medical • Cadwell Laboratories • Denshi • Medline • Samsung • ADC • Care Innovationsm • GE Healthcare • Medocity • Santa Medical • Advanced Brain Monitoring • Carewell • GlobalMed • Mennen Medical • Schiller • Advantage Home Telehealth • CAS Medical Systems • Telemedicine • Merit • Smiths Medical • Aerotel Medical Systems, • Cheetah Medical • Graham-Field • Microlife • Sophysa • AmbioHealth • ChoiceMMed • HoMedics • Neoventa • Spielberg • Ambu • Cnsystems • Huntleigh Healthcare • Nihon Kohden • SunTech Medical • AMC Healthcare • Codman & Shurtleff, • Hutchinson Technology • OBS Medical • Teleflex Medical • AMD Global • Compumedics • HydroDotICU Medical • Optum (UnitedHealth) • Tensys • Telemedicine • Constant Care Technology • IdealLife • Ornim Medical • Tunstall Healthcare • American Telecare • Contec Medical Systems • Infinium Medical • Osypka Medical • USCOM • American Well • Criticare Systems • Integra Lifesciences • Panasonic • Utah Medical
• AnalogicCorporation • Deltex Medical • Ives EEG Solutions • Philips Healthcare • Veridian Healthcare • Argon Medical • Devon Medical • Ivy • Physioflow • ViTel Net (ViTelCare) • AuthentiDate • Dräger Medical • Biomedical • Polymap Wireless • Viterion Telehealthcare • Avizia • EBNeuro • Labtron • Prestige Medical • VRI • B. Braun • Edwards Lifesciences • LG CNS • Pulsion Medical • WA Baum • Biolight • Electro Geodesics • LiDCO • Qardio • Welch Allyn • Biotronik • Entra Health • LifeWatchAG • RAUMEDIC • Zoe Medical • Briggs Healthcare • Fukuda • Mediaid Inc. • RhythmLink • Zynex Medicaletc
